Viewing nowMediKinet Retard Capsule 5mg (Methylphenidate Hydrochloride)
Methylphenidate Hydrochloride 2.5mg
Prescription medication
Myungjin Pharmaceutical Co., Ltd.

MFDS item code 201111086 · Approved 2011.12.22 · Insurance code 651903630
Treatment of attention-deficit/hyperactivity disorder (ADHD) in patients aged 6 years and older
This medication is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents, and adults aged 6 and older. ADHD is characterized by persistent symptoms of inattention, hyperactivity, and impulsiveness that cause significant impairment in social or academic functioning across various settings such as school and home. Diagnosis should be made according to DSM-IV or ICD-10 criteria, distinguishing symptoms from other mental disorders. This medication is not used alone but is an important part of a comprehensive treatment program that includes psychosocial and educational interventions. Not all patients require pharmacotherapy; it is prescribed for those with chronic or severe symptoms, based on a doctor's evaluation. Therefore, this medication is effectively used to improve ADHD symptoms.
The dose of this medicine should be individualized according to the patient's response and tolerability. This medicine should be administered with a meal or immediately after a meal. If a patient taking another formulation of methylphenidate hydrochloride is switched to this medicine, it must be administered immediately after a meal. Take this medicine, or its contents, intact with water. Do not chew or crush the contents of this medicine. ○ Adults Administer this medicine 2 times a day (morning and noon), immediately after meals. The initial dose is 5mg per dose, administered 2 times a day (morning and noon). Increase the daily dose by 10mg each week according to the patient's treatment response and tolerability. The maximum daily dose of this medicine is 1mg/kg and must not exceed 80mg a day. Adult patients who have been continuously taking this medicine since childhood or adolescence should continue taking the same dose they are currently taking. 2. Maintenance and long-term treatment The safety and efficacy of this medicine for long-term administration for more than 6 months have not been studied. When prescribing this medicine long term to patients with ADHD, periodically reassess its efficacy for long-term use by temporarily interrupting drug treatment and conducting a trial to evaluate the patient's social functioning. 3. Dose reduction and discontinuation If symptoms worsen or other adverse reactions occur, reduce the dose and, if necessary, discontinue this medicine. If symptoms do not improve within one month after adjustment to an appropriate dose, discontinue this medicine.
○ Children and adolescents aged 6 years and older: Administer this medicine once a day, immediately after breakfast. The initial dose is 5mg per dose, administered once a day (in the morning) or 2 times a day (morning and noon). Increase the daily dose by 5 ~ 10mg each week according to the patient's treatment response and tolerability. The maximum daily dose of this medicine is 60mg.
This medication should not be used in patients with known heart problems or those at high risk for cardiovascular diseases. In particular, patients with heart abnormalities or hypertension should have their blood pressure and heart rate monitored periodically. Patients with psychiatric disorders or bipolar disorder should consult a doctor before taking this medication, as symptoms may worsen. Children or adolescents may exhibit new psychotic symptoms or aggressive behavior, necessitating careful observation. Long-term use could affect growth, requiring close monitoring of height and weight changes. Patients with a history of seizures may have an increased risk of convulsions, thus careful administration is warranted. If any visual symptoms arise, such as changes in vision, immediate consultation with a physician is required. This medication is not considered safe for children under 5 years old. Patients with a history of drug dependence or alcohol addiction should avoid adjusting the dosage themselves. Priapism may occur, and immediate medical attention is warranted for any unusual symptoms. Peripheral vascular disease may rarely manifest, so changes in color or pain in the hands or feet should be observed. Patients with severe anxiety, tension, or excitement should refrain from using this medication. Patients with glaucoma or certain genetic disorders should also avoid this medication. Drug interactions may occur, so all currently taken medications must be reported to the doctor. In pregnant or nursing women, the use should be determined after consulting a physician. It is advised to take this medication with food or after meals, swallowing the capsules whole or sprinkling the contents over applesauce for immediate consumption. Caution is advised when driving or operating machinery, as dizziness may occur. Keep out of reach of children and store in the original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is best to maintain a storage temperature between 1°C and 30°C. Proper storage will help preserve the efficacy and safety of the medication.
A hard capsule with a white upper and lower body containing fast-release white pellets and enteric-coated blue pellets.
30 capsules (10 capsules/PTP×3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMethylphenidate Hydrochloride 2.5mg
Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Methylphenidate Hydrochloride 5mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Methylphenidate Hydrochloride 10mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Methylphenidate Hydrochloride 10mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Methylphenidate Hydrochloride 20mg
Hard capsule · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Methylphenidate Hydrochloride 5mg
Hard capsule · Prescription medication
Myeongin Pharmaceutical Co., Ltd.

Methylphenidate Hydrochloride 10mg
Hard capsule · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Methylphenidate Hydrochloride 15mg
Hard capsule · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.